CDC vaccine panel delays hepatitis B vote amid chaotic meeting

The CDC advisory panel has once again delayed a vote on hepatitis B vaccines, following a tumultuous meeting that raised concerns about misinformation. This postponement continues to stall the decision-making process regarding the vaccination recommendations for newborns.

The CDC's vaccine advisory panel has postponed a crucial vote on hepatitis B vaccines following a tumultuous meeting characterized by misinformation. This delay raises concerns about the decision-making process regarding public health vaccines.

Former President Donald Trump has intensified his attacks on Somali immigrants, labeling them as detrimental to the United States and expressing a desire for them to leave the country. This rhetoric coincides with anticipated immigration enforcement actions in Minnesota, where a significant Somali community resides.

The vaccine advisory committee for the Centers for Disease Control and Prevention (CDC) is preparing to vote on the future of the hepatitis B vaccine for newborns, a decision that has raised concerns within the medical community. This vote could potentially reverse the long-standing recommendation for administering the vaccine within 24 hours of birth, a practice that has been in place for decades.

Former President Donald Trump has intensified his attacks on Somali immigrants, claiming they have negatively impacted the United States and suggesting that they should leave the country. This follows a series of derogatory remarks made during media events and cabinet meetings, where he labeled the Somali community as 'garbage' and criticized local leaders who support them.

A group of advisers to the Centers for Disease Control and Prevention (CDC) is set to vote on potentially reversing the long-standing recommendation for newborns to receive a hepatitis B vaccination within 24 hours of birth. This decision could significantly alter vaccination protocols for infants in the United States.